Vitiligo and steroids
Brostoff, H.; Brostoff, J.
Lancet 2(8091): 688
1978
ISSN/ISBN: 0140-6736 PMID: 80625 DOI: 10.1016/s0140-6736(78)92812-xDocument Number: 497222
Document emailed within 0-6 h
Related Documents
Tóth, I.; Faredin, I. 1983: Steroids excreted by human skin. I. C19-steroids in axillary hair Acta Medica Hungarica 40(2-3): 139-145Korneev, G.I. 1972: Urinary excretion of C-21 and C-19 steroids in various periods of postmenopausal period in patients suffering from climacteric neurosis under the effect of treatment with estrogens and hormone-inactive anabolic steroids Problemy Endokrinologii 18(2): 27-35
Amenábar, J.J.; Gómez-Ullate, P.; García-López, F.J.; Aurrecoechea, B.; García-Erauzkin, G.; Lampreabe, I. 1998: A randomized trial comparing cyclosporine and steroids with cyclosporine, azathioprine, and steroids in cadaveric renal transplantation Transplantation 65(5): 653-661
Huppertz, H.I.; Frosch, M.; Kuhn, C.; Christen, H.J.; German, J.D.M. 1998: Treatment of juvenile dermatomyositis with high-dose oral steroids or with steroid-pulse-therapy plus low-dose oral steroids Arthritis and Rheumatism 41(9 Suppl): S264
Lebranchu, Y.; Aubert, P.; Bayle, F.; Bedrossian, J.; Berthoux, F.; Bourbigot, B.; Buchler, M.; Chalopin, J.M.; Deteix, P.; Glotz, D.; Huraut De Ligny, B.; Kessler, M.; Lang, P.; Lefrancois, N.; Le Pogamp, P.; Moulin, B.; Mourad, G.; Olmer, M.; Sraer, J.D.; Touchard, G.; Toupance, O.; Wolf, P.; Puget, S. 2000: Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group Transplantation Proceedings 32(2): 396-397
Studnitsin, A.A. 1979: Vitiligo Fel'dsher i Akusherka 44(4): 60-61
Alhaidari, Z. 2000: Cat vitiligo Annales de Dermatologie et de Venereologie 127(4): 413
Lassus, A.; Apajalahti, A.; Blomqvist, K.; Mustakallio, M.; Kiistala, U. 1972: Vitiligo and neoplasms Acta Dermato-Venereologica 52(3): 229-232
Verma, K.C.; Jain, V.K. 1981: Dermatoglyphics in Vitiligo Indian Journal of Dermatology Venereology and Leprology 47(2): 102-104
Gokhale, B.B.; Parakh, A.P. 1983: Cyclophosphamide in vitiligo Indian Journal of Dermatology 28(1): 7-10
Arroyo, M.P.; Tift, L. 2003: Vitiligo therapy: where are we now? Journal of Drugs in Dermatology: Jdd 2(4): 404-408
Thurmon, T.F.; Jackson, J.; Fowler, C.G. 1976: Deafness and vitiligo Birth Defects Original Article Series 12(5): 315-320
Sharma, L.; Bhawan, R.; Jain, R.K. 2004: Hypoacusis in vitiligo Indian Journal of Dermatology Venereology and Leprology 70(3): 162-164
Herbst, R.A. 2007: New treatments for vitiligo? Medizinische Monatsschrift für Pharmazeuten 30(10): 379-380
Fisher, A.A. 1976: Vitiligo due to contactants Cutis 17(3): 431-437; 438
Bakry, O.A.; Hammam, M.A.; Abdel Wahed, M.M. 2013: Vitiligo: is it grace or curse? Acta Dermatovenerologica Croatica: Adc 21(2): 71-79
Koshevenko, I.N. 1984: Clinical characteristics of vitiligo Vestnik Dermatologii i Venerologii 3: 60-63
Dolecek, R. 1983: Metyrapone in the therapy of vitiligo Casopis Lekaru Ceskych 122(18): 564-567
Nahhas, A.F.; Braunberger, T.L.; Hamzavi, I.H. 2019: Update on the Management of Vitiligo Skin Therapy Letter 24(3): 1-6
Mohan, L.; Singh, G.; Kaur, P.; Pandey, S.S.; Mohan, R.; Niyogi, A.K. 1982: Vitiligo: a genetic evaluation Indian Journal of Dermatology 27(3): 77-85